French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator

ConditionsTetralogy of Fallot Implantable Defibrillator User Congenital Heart Disease Sudden Cardiac Death Ventricular Arrythmia

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorParis Sudden Death Expertise Center

About this trial

National french registry of patients with tetralogy of Fallot and implantable cardioverter defibrillator.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

tetralogy of Fallot

implantable cardioverter defibrillator

Disqualifiers

age < 18 years

Trial population

All adult patients with tetralogy of Fallot and implantablle cardioverter defibrillator in France

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

Ventricular arrhythmias

Rate of appropriate ICD therapies for ventricular tachycardia and fast ventricular tachycardia / ventricular fibrillation

Time frame

through study completion, an average of 1 year

Complications of ICD

Rate of complications of ICD including inappropriate therapies, infection, lead or generator dysfunction

Time frame

through study completion, an average of 1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Paris Sudden Death Expertise Center

Lead sponsor

Source ClinicalTrials.gov

Apply now